Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F5A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,611
Award facts
- Contract value 100% obligated
- $13,610.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $13,610.58 delivery order for KEVZARA (sarilumab) 200 mg/1.14 mL pen injections on January 2, 2026, with completion scheduled for January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products ranging from specialty medications to generic drugs across multiple therapeutic domains. This delivery order for KEVZARA, a prescription treatment for rheumatoid arthritis, reflects AmerisourceBergen's ongoing role in maintaining the pharmaceutical supply chain for Department of Defense and veteran healthcare requirements. The firm fixed-price structure and rapid completion timeline underscore the efficiency of the delivery order mechanism for fulfilling immediate medical supply needs within the broader global pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DR26F5F5A?
SPE2DR26F5F5A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F5F5A worth?
The government has obligated $13,611 on SPE2DR26F5F5A.
Is contract SPE2DR26F5F5A an order under another contract?
Yes. SPE2DR26F5F5A is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F5A competed?
The extent of competition for SPE2DR26F5F5A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award